leucine/isoleucine/arginine/glutamine/N-acetylcysteine/carnitine/serine (AXA1957)
/ Axcella
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 18, 2021
Multifactorial effects of AXA1125 and AXA1957 observed on markers of metabolism, inflammation and fibrosis: a 16-week randomized placebo-controlled study in subjects with nonalcoholic fatty liver disease (NAFLD) with and without type 2 diabetes (T2D)
(EASL-NAFLD 2021)
- No abstract available.
1 to 1
Of
1
Go to page
1